Symbols

LBRX

LB Pharmaceuticals·NASDAQ

--(--)

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About LBRX

Lb Pharmaceuticals Inc

A clinical stage biopharmaceutical company specializing in the research and development of therapies for neurological and psychiatric disorders

Industry

Pharmaceutical

Established Date

Listing Date

09/11/2025

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.lbpharma.us

Security Type

Common stock

Office address

One Pennsylvania Plaza Suite 1025 New York NY 10119

Business

Introduction

LB Pharmaceuticals Inc was incorporated under the laws of the State of Delaware in September 2015. The company is a clinical-stage biopharmaceutical company developing novel therapies for the treatment of schizophrenia, bipolar depression and other neuropsychiatric disorders.

Company Financials

EPS

LBRX has released its 2025 Q3 earnings. EPS was reported at -0.61, versus the expected 0, missing expectations. The chart below visualizes how LBRX has performed over recent quarters, highlighting trends in earnings surprises.